Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity

World Journal of Gastroenterology

Volumn 10, Issue 24, 2004, Pages 3590-3596

  Fu, Xiao Bing ^a   Li, Xiao Kun ^b   Wang, Tong ^b   Cheng, Biao ^a   Sheng, Zhi Yong ^a  

^a Institute of Burns   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; CALCIUM ION; DEXAMETHASONE; DNA FRAGMENT; MITOGEN ACTIVATED PROTEIN KINASE 1;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM BALANCE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION; GENE VECTOR; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INTESTINE EPITHELIUM; INTESTINE ISCHEMIA; MITOGENESIS; MOLECULAR CLONING; MOUSE; NONHUMAN; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM; STOMACH PROTECTION; THYMOCYTE; WILD TYPE;

EID: 10244253940     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i24.3590     Document Type: Article

References (33)

1. Galzie Z, Kinsella AR, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol 1997; 75: 669-685
2. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993; 362: 844-846
3. Nurcombe V, Ford MD, Wildschut JA, Bartlett PF. Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 1993; 260: 103-106
4. Fu X, Sheng Z, Wang Y, Ye Y, Xu M, Sun T, Zhou B. Basic fibroblast growth factor reduces the gut and liver morphologic and functional injuries after ischemia and reperfusion. J Trauma 1997; 42: 1080-1085
5. Cuevas P, Reimers D, Carceller F, Martinez-Coso V, Redondo-Horcajo M, Saenz de Tejada I, Gimenez-Gallego G. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury. Eur J Med Res 1997; 2: 465-468
6. Cuevas P, Carceller F, Reimers D, Gimenez-Gallego G. Fibroblast growth factor-1 inhibits medial smooth muscle cells apoptosis after balloon injury. Neurol Res 2000; 22:185-188
7. Wan X, Nass P, Duncan MD, Harmon JW. Acidic fibroblast growth factor overexpression partially protects 3T3 fibroblasts from apoptosis induced by synthetic retinoid CD437. J Mol Med 2001; 79: 143-148
8. Lozano RM, Pineda-Lucena A, Gonzalez C, Angeles Jimenez M, Cuevas P, Redondo-Horcajo M, Sanz JM, Rico M, Gimenez-Gallego G. 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. Biochemistry 2000; 39: 4982-4993
9. Yang YH, Fu XB, Sun TZ, Jiang LX, Gu XM. bFGF and TGFβ expression in rat kidneys after ischemic/reperfusional gut injury and its relationship with tissue repair. World J Gastroenterol 2000; 6 147-149
10. Fu XB, Yang YH, Sun XQ, Sun TZ, Gu XM, Sheng ZY. Protective effects of endogenous basic fibroblast growth factor activated by 2, 3 butanedion moncime on functional changes of ischemic intestine, liver and kidney in rats. Zhongguo Weizhongbing Jujiu Yixue 2000; 12: 69-72
11. Yang YH, Fu XB, Sun TZ, Jiang LX, Gu XM. The effect of exogenous basic fibroblast growth factor on hepatic endogenous basic fibroblast growth factor and fibroblast growth factor receptor expression after intestinal ischemia-reperfusion injury. Zhongguo Weizhongbing Jijiu Yixue 1999; 11: 734-736
12. Fu XB, Yang YH, Sun TZ, Sun XQ, Gu XM, Chang GY, Sheng ZY. Effects of inhibition or anti-endogenous basic fibroblast growth factor on functional changes in intestine, liver and kidneys in rats after gut ischemia-reperfusion injury. Zhongguo Weizhongbing Jujiu Yixue 2000; 12: 465-468
13. Sun XQ, Fu XB, Zhang R, Lü Y, Deng Q, Jiang XG, Sheng ZY. Relationship between plasma D (-)-lactate and intestinal damage after severe injuries in rats. World J Gastroenterol 2001; 7: 555-558
14. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556
15. Voris BP, Young DA. Glucocorticoid-induced proteins in rat thymus cells. J Biol Chem 1981; 256: 11319-11329
16. McConkey DJ, Nicotera P, Hartzell P, Bellomo G, Wyllie AH, Orrenius S. Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch Biochem Biophys 1989; 269: 365-370
17. McConkey DJ, Zhivotovsky B, Orrenius S. Apoptosis-molecular mechanisms and biomedical implications. Mol Aspects Med 1996; 17: 1-110
18. Fernandez A, Kiefer J, Fosdick L McConkey DJ. Oxygen radical production and thiol depletion are required for Ca (2+)-mediated endogenous endonuclease activation in apoptotic thymocytes. J Immunol 1995; 155: 5133-5139
19. Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14: 452-460
20. Udayakumar TS, Stratton MS, Nagle RB, Bowden GT. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3. Neoplasia 2002; 4: 60-67
21. Buehler A, Martire A, Strohm C, Wolfram S, Fernandez B, Palmen M, Wehrens XH, Doevendans PA, Franz WM, Schaper W, Zimmermann R. Angiogenesis-independent cardioprotection in FGF-1 transgenic mice. Cardiovasc Res 2002; 55: 768-777
22. Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J, Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X (L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 2000; 79: 355-369
23. Min do S, Shin EY, Kim EG. The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells. Exp Mol Med 2002; 34: 38-46
24. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 2002; 22: 7802-7811
25. Harrington EA, Bennett MR, Fanidi A, Evan GI. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994; 13: 3286-3295
26. Amati B, Littlewood TD, Evan GI, Land H. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 1993; 12: 5083-5087
27. Green DR. A Myc-induced apoptosis pathway surfaces. Science 1997; 278: 1246-1247
28. Winters ZE. P53 pathways involving G2 checkpoint regulators and the role of their subcellular localisation. J R Coll Surg Edinb 2002; 47: 591-598
29. Adachi S, Obaya AJ, Han Z, Ramos-Desimone N, Wyche JH, Sedivy JM. c-Myc is necessary for DNA damage-induced apoptosis in the G (2) phase of the cell cycle. Mol Cell Biol 2001; 21: 4929-4937
30. Young M, Oger J, Blanchard MH, Asdourian H, Amos H, Arnason BG. Secretion of a nerve growth factor by primary chick fibroblast cultures. Science 1975; 187: 361-362
31. Kumagai A, Dunphy WG. Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. Nat Cell Biol 2003; 5: 161-165
32. Fu X, Sun X, Li X, Sheng Z. Dedifferentiation of epidermal cells to stem cells in vivo. Lancet 2001; 358: 1067-1068
33. Fu X, Shen Z, Cheng Y, Xe J, Guo Z, Zhang M, Sheng Z. Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet 1998; 352: 1661-1664